Skip to content

SAVE: School Ambassadors for Vaccine Education

SAVE: School Ambassadors for Vaccine Education

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07164144
Enrollment
6000
Registered
2025-09-09
Start date
2026-05-01
Completion date
2027-09-01
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza Vaccination

Brief summary

Influenza is associated with millions of cases of school absenteeism due to illness, hundreds of hospitalizations and thousands of deaths in the U.S. each year, which can be greatly reduced with influenza vaccination. The goal of this randomized controlled trial is to learn if training school personnel in vaccine communication techniques and equipping schools with vaccine promotional materials targeting students and their parents/guardians increases the influenza vaccination rates of the student population within participating schools. The main question it aims to answer is: -Will flu vaccination rates be higher in intervention schools compared to control schools by the end of the intervention period? Participating schools will: * Have select school personnel (school nurses, coaches, teachers, etc.) complete an online training module and optional training workshop focused on vaccine communication \[intervention arm only\] * Utilize vaccine promotional materials (posters, flyers, digital files for social media, etc.) provided by the study team during flu season \[intervention arm only\] * Track student vaccination rates \[intervention + control arm\]

Interventions

BEHAVIORALVaccine Communication Training

School personnel receive vaccine communication training + promotional materials

Sponsors

University of Rochester
Lead SponsorOTHER
Centers for Disease Control and Prevention
CollaboratorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 21 Years
Healthy volunteers
Yes

Inclusion criteria

* A student enrolled in a participating school (intervention or control) for at least two years

Design outcomes

Primary

MeasureTime frame
Flu vaccination rate8 months (one flu season August-March)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026